Stromal CYR61 Confers Resistance to Mitoxantrone via Spleen Tyrosine Kinase Activation in Human Acute Myeloid Leukaemia

E-ISSN： 1365-2141|170|5|704-718

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.170, Iss.5, 2015-09, pp. : 704-718

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spleen tyrosine kinase contributes to acute renal allograft rejection in the rat

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (ELECTRONIC), Vol. 96, Iss. 1, 2015-02 ,pp. : 54-62

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance‐conferring FLT3/tyrosine kinase domain/F691 mutation

CANCER, Vol. 124, Iss. 2, 2018-01 ,pp. : 306-314

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute myeloid leukaemia in pregnancy

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 4, 2015-08 ,pp. : 441-442

John Wiley & Sons Inc

Access to resources Recommend Favorite

CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib‐resistant chronic myeloid leukaemia

THE JOURNAL OF PATHOLOGY, Vol. 237, Iss. 1, 2015-09 ,pp. : 14-24

John Wiley & Sons Inc

Access to resources Recommend Favorite

A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 years

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 40, Iss. 4, 2015-08 ,pp. : 391-397

John Wiley & Sons Inc

Access to resources Recommend Favorite